BIVI

BioVie Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 3/01/2017
Contact Info
  • 100 Cummings Center
  • Suite 247-C
  • Beverly, MA 01915

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001580149
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2013
Employees Not Available
Company Officers/Contacts
Jonathan Adams CEO, CFO
Amrit Shahzah President, Corporate Secretary
Company Directors
Jonathan Adams Chairman
Cuong Do
James Lang
Amrit Shahzah
Service Providers
Accounting/Auditing Firm
South Loop CPA
1006 S Michigan Ave
Suite 202
Chicago, IL, 60605
United States
 
Securities Counsel
Brown, Gee & Wenger LLP
200 Pringle Ave, Suite 400
Walnut Creek, CA, 94596
United States
 
Investor Relations Firm
Content Carnivores, LLC
222 Merchandise Mart Plaza
Chicago, IL, 60654
United States
 
Company History
  • Formerly=NanoAntibiotics, Inc. until 8-2016
BIVI Security Details
Share Structure
Market Value1 $25,939,396 a/o Jun 27, 2017
Authorized Shares 300,000,000 a/o May 31, 2017
Outstanding Shares 91,925,000 a/o May 31, 2017
-Restricted 69,259,517 a/o May 31, 2017
-Unrestricted 22,665,483 a/o May 31, 2017
Held at DTC 22,665,483 a/o May 31, 2017
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
West Coast Stock Transfer Inc.
Shareholders
Shareholders of Record 87 a/o Sep 28, 2016
Short Selling Data
Short Interest 463 (27.55%)
May 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security